[
    [
        {
            "time": "2021-06-15",
            "original_text": "广誉远“傍着”片仔癀飙涨87.44%，国家保密品种营收却同比下降三、四成 盈利能力下降",
            "features": {
                "keywords": [
                    "广誉远",
                    "片仔癀",
                    "飙涨",
                    "国家保密品种",
                    "营收下降",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "广誉远“傍着”片仔癀飙涨87.44%，国家保密品种营收却同比下降三、四成 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-16",
            "original_text": "南京医药：漳州片仔癀药业股份有限公司系公司控股子公司福建同春药业股份有限公司第二大股东，股权占比24%",
            "features": {
                "keywords": [
                    "南京医药",
                    "片仔癀",
                    "福建同春药业",
                    "股权占比"
                ],
                "sentiment_score": 0.0,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "南京医药：漳州片仔癀药业股份有限公司系公司控股子公司福建同春药业股份有限公司第二大股东，股权占比24%",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-17",
            "original_text": "A股中药概念股PK：一季度22股净利过亿 广誉远股价年内涨幅最高",
            "features": {
                "keywords": [
                    "A股",
                    "中药概念",
                    "广誉远",
                    "股价涨幅"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股中药概念股PK：一季度22股净利过亿 广誉远股价年内涨幅最高",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-18",
            "original_text": "热点解读！“药中茅台”片仔癀的背后——中药材已经“势不可挡”",
            "features": {
                "keywords": [
                    "药中茅台",
                    "片仔癀",
                    "中药材",
                    "势不可挡"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "热点解读！“药中茅台”片仔癀的背后——中药材已经“势不可挡”",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-19",
            "original_text": "国资入主，股价暴涨，广誉远能否成为下一个片仔癀？",
            "features": {
                "keywords": [
                    "国资入主",
                    "广誉远",
                    "片仔癀",
                    "股价暴涨"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国资入主，股价暴涨，广誉远能否成为下一个片仔癀？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-20",
            "original_text": "老字号“焕”新活力，品牌中药风头正劲",
            "features": {
                "keywords": [
                    "老字号",
                    "品牌中药",
                    "新活力",
                    "风头正劲"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "老字号“焕”新活力，品牌中药风头正劲",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-06-21",
            "original_text": "半个月翻倍，比片仔癀还猛！冯柳精准抄底，山西国资控股！市盈率超2000倍的老字号，会成为下一个中药龙头吗？",
            "features": {
                "keywords": [
                    "片仔癀",
                    "冯柳",
                    "山西国资",
                    "市盈率",
                    "中药龙头"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "中药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "半个月翻倍，比片仔癀还猛！冯柳精准抄底，山西国资控股！市盈率超2000倍的老字号，会成为下一个中药龙头吗？",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]